SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $259M invested in SPDR S&P Pharmaceuticals ETF in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 14 closing their positions.
Holders
71
Holders Change
-5
Holders Change %
-6.58%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
16
Reduced
24
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$19.6M |
2 |
2
LPL Financial
San Diego,
California
|
$3.65M |
3 |
3
UBS Group
Zurich,
Switzerland
|
$18.7M |
4 |
EC
4
Estate Counselors
Thiensville,
Wisconsin
|
$0 |
5 |
CS
5
Credit Suisse
Zurich,
Switzerland
|
$439K |